BioProduction 2010

Conference Overview

Join us to explore the latest advances in the design and development of cell lines for increased production levels and learn how to rationalise your processes, decrease production costs and optimise your downstream processing to match the increasing demands of high titers.

It is estimated that 30% of new drugs likely to be licensed during the next decade will be based on antibody products. Join us to explore advances in the design and development of cell lines for increased production levels; learning how to rationalise your processes, decrease production costs and optimise your downstream processing to match the increasing demands of high titres – don’t miss:

KEY SPEAKERS:

Professor David James, Professor of Bioprocess Engineering, Department of Chemical and Process Engineering, University of Sheffield, UK

Dr Srikanth R. Chary, Principal Engineer, Genentech, USA

Dr Mark Uden, Head of Mammalian Process Research, GlaxoSmithKline, UK

Dr Alexander Jacobi, Associate Director, Downstream Development, Boehringer Ingelheim, GERMANY

Dr Tom Lecocq, Late Stage Cell Culture, Genentech, Inc., USA

Professor Massimo Morbidelli, Head, The Morbidelli Group, ETH Zurich, Switzerland

Dr Jianguo Yang, Principal Scientist and Group Leader, Genzyme, USA

Dr Anthony Newcombe, Purification Lead, Pfizer Biotechnology Ireland, Ireland

Dr Majid Mehtali, Managing Director, Chief Scientific Officer, Vivalis, France

Dr Corinna Sonderegger, Technical Development Strategy, Sandoz GmbH, Austria

Quite interesting in current technology information
(Genhelix Spain)

Very interesting and focusing
(ROUICM)

Instantaneous Industrial Nice Picture = The event contains all the relevant information I need to know today.
(Merck Serono Biodevelopment)

In general interesting
(CEVEC Pharmaceuticals)

Well conducted and useful conference. Good speakers and nice location.
(DSM Biologics BV)

A clever interface between basic science and production.
(Medicago inc)

A resumé of the most important items in biotech forums.
(Genhelix Spain)

Very good overview of current industry practices and areas of interest.
(Pfizer Inc)

Large and diverse conference, maybe too large. Excellent, driven speakers.
(Toxicon)

Good event in a nice city.
(NNE Pharmaplan)

Very high quality presentations. A clear picture of QbD for biotechs.
(Sanofi-Aventis)

It was ok, but I took a number of useful notes.
(ETH Zurich)

Workshops were good and informative
(Teva Pharmaceuticals)

Interesting, my first EU conference.
(Sandoz)

Interesting speakers, well arranged, good networking opportunities.
(GE Healthcare)

Excellent organization, good selection of speakers. Some focus on drug product regulatory and quality would be appreciated. Nice venue facility.
(Kuros Biosurgery AG)

A great opportunity to network and meet up with colleagues.
(Biopharm Services)

Good networking opportunities and useful for viewing future Bioproduction trends.
(Laboratorios Hipra SA)

Very informative conference in a beautiful city.
(Centocor)

Excellent in depth coverage of subject areas.
(Domantis Ltd)

Good organisation and good opportunity for
networking. Interesting technical presentations.
(GlaxoSmithKline Biologicals)

Good networking, content level useful, some conferences better than other
(Sealed Air)

Excellent event! The possibility to switch between four conferences made the attendance most valuable for me!
(Suppremol)

The conference is perfectly organised, enabling highly efficient exchange among the participants.
(Novartis Biologics)

Very useful and well organised.
(GlaxoSmithKline R&D)

Good condensed update on the state and trends of the Bioproduction Business.
(Merck Serono)

Focused – good technical and process content.
(LFB Biotechnologies)

This was an interesting opportunity to speak to a variety of QbD experts and to hear what we should incorporate in our Masters programme.
(De Montfort University)

Event Links

Conference

Sponsorship

Exhibitors

Media Partners

Marketing Tools

Antibody Production and Downstream Processing (CQ3425)

Conference Overview

KEY SPEAKERS:

Corporate Sponsors

Associate Sponsor